Obesity and weight gain has negative impact on graft survival and is at least partially responsible for diabetes, which supports more focused, weight-centered approach to treatment.28-30 Although we were not able to show significant weight loss in our patients, the trend was a reduction in weight and significant decrease in insulin dose, which may have further beneficial effects on both weight loss and amelioration of hypoglycemic events. This evidence concerns the gene INS and obesity disorder.